The Government's updated Exotic Animal Disease Contingency Plan was laid in Parliament today.
The revised plan is produced by Animal Health for Defra, and includes changes which have been subject to formal public consultation. This includes a framework response plan for dealing with exotic animal diseases and plans for responding to specific diseases including Foot and Mouth Disease, Avian Influenza and Newcastle Disease.
The changes to the plan reflect lessons identified from the incidents handled during 2008 and address recommendations made in Sir Iain Anderson's review of the 2007 outbreak of Foot and Mouth Disease and feedback from the public consultation.
Jane Kennedy, Minister for Farming and the Environment said: "An animal disease outbreak can be devastating for those concerned. Defra remains totally committed to ensuring we learn lessons from our experience of outbreaks, so that we can make sure we respond effectively in future".
The Contingency Plan is subject to ongoing revision based on the latest scientific advice, developments in policy, comments from stakeholders and operational partners together with the lessons identified from disease outbreaks. It can be accessed here:www.defra.gov.uk/animalh/diseases/control/contingency/index.htm
To meet market demands and ensure that their customers comply with regulatory requirements, British manufacturer Labcold has released the first models in a new range of vaccine and pharmaceutical refrigerators designed specifically for this use from the ground-up. The company says more models will be added to the range over the next 12 months.
When storing temperature-sensitive vaccines and pharmaceuticals, Veterinary Practices need to ensure compliance with an ever-increasing burden of legislation, regulations and guidelines, such as the latest VMD Code of Practice, (Oct 2007). The BVA Good Practice Guide - Standard Operating Procedure 04 on the storage of medicinal products in permanent premises says as follows:
Refrigerated storage must:
Although this guidance stops short of specifically excluding the use of domestic refrigerators, Labcold says professional products are more appropriate since they are built specifically for vaccine and pharmaceutical storage. Labcold refrigerators all fully compliant and have locking doors plus a host of handy options including capacity, glass doors and a new divided-drawer system.
Robin Gregson, Sales & Marketing Director at Labcold said, "Our whole product range is constantly being updated to ensure that we provide our customers with market-leading solutions. Many previous pharmacy refrigerators have simply been modified designs of domestic fridges, whilst our new range, the result of three years work, is one of the few on the market to be designed specifically for pharmacy use from the ground up."
For full information on all Labcold products, including portable refrigerators suitable for farm vets please visit http://www.labcold.com/ or contact sales@labcold.com / Telephone 0870 3001001 for a free copy of the latest Product Guide.
The BVA has added its voice to calls for the suspension of imports of cattle and sheep from areas where the bluetongue virus is known to be circulating.
Following yesterday’s announcement by Defra that BTV1 (Bluetongue Serotype 1) had been detected in five cattle imported from a Restricted Zone in the south west of France, BVA President Nicky Paull said: “I am saddened, but not surprised, that the actions of some are putting our livestock here in the UK at risk. As long as some farmers continue to import stock from these areas we will continue to see this problem and we therefore believe that the only answer is to suspend imports. We also see absolutely no reason why compensation should be paid to those who have risked the health and welfare of the national flock and herd.
“My advice to farmers still is to vaccinate against BTV8 if you have not done so already. If you did vaccinate during the summer then plan to boost protection at the end of the winter period so your stock is protected next summer. With no vaccine currently licensed for BTV1 however, do not import livestock from mainland Europe - we should not rely on the hope of a BTV1 vaccine in time to prevent serious problems next summer if we buy this new strain of bluetongue virus into the UK.”
Defra has announced the detection of Bluetongue (Serotype 1) (BTV1) in five imported cattle on a premises near Blackpool in Lancashire.
The animals originated from within the BTV1 and 8 Restricted Zone in the south west of France and were detected as a result of post-import testing carried out by Defra on all Bluetongue susceptible animals arriving from continental Europe. The animals' documentation complied with the EU Bluetongue rules governing the movement of livestock as the movement occurred at least 60 days after they had been vaccinated.
This is the first case of BTV1 infection in the UK and the five animals have been culled as they may pose a disease threat to other animals. One further animal from the same consignment has also been culled. Test results for that animal were positive for bluetongue although it was not possible to determine the serotype.
There is no evidence that BTV1 is circulating in the UK and no additional control zones have been declared.
This response is in accordance with Defra's Bluetongue Control Strategy. The premises are now under restriction while an epidemiological investigation takes place. This will include further checks on the other animals present on the premises.
Chief Veterinary Officer Nigel Gibbens said: "This is the first case of BTV1 infected animals being imported into the UK. Taking into account the epidemiological evidence and the consideration of the risk represented to British livestock, I have taken the decision to cull these animals.
"This incident shows how important it is for farmers to consider potential disease risks when buying stock. Buyers need to consider how best to protect their own businesses and those of their neighbours and make sure they are clear about the stock they are intending to buy."
Defra continues to test all susceptible animals imported to the UK from continental Europe for all strains of Bluetongue and continues to urge industry to consider the risks and check the health and vaccination status of animals when sourcing any animals from within the UK or abroad.
In line with EU legislation, and our UK Control Strategy agreed with industry, control measures are in place in UK and abroad to prevent the spread of Bluetongue from existing zones around Europe:
The ‘Midgeater' device introduced by Calor in 2003 to combat biting midges causing irritation to humans, has now been successfully tested by leading scientists as a monitoring device in the fight against bluetongue.
Leading midge scientist Dr Alison Blackwell, who is the Managing Director of University of Edinburgh based Advanced Pest Solutions, presented her company's findings in her keynote speech to the Royal Entomological Society in Belfast on November 19th.
The current method of trapping midges when monitoring the deadly bluetongue virus is a light trap, but Alison and her team have established that a modified Midgeater can be more effective in catching the main midge species that carry the virus.
Alison said: "During trials this year, we found that Calor fuelled Midgeater traps modified with a simple ‘black' light source and fitted with an octenol / ammonia bait, proved to be far more effective at catching the main species of midge known to carry the bluetongue virus than the light traps which are currently used to monitor midge populations in relation to the disease".
Farmers throughout the UK recently commenced a vaccination programme to protect their animals from the only strain of the bluetongue virus that has so far been encountered in the UK, serotype 8, but there is still a real need to carefully monitor biting midge populations, as other strains of the virus are approaching our shores.
Alison added: "In the last few weeks serotype 1 and serotype 6 have been found in Northern Europe and there are currently no vaccines available in the UK for these types of the bluetongue virus, so it is important that we remain vigilant and monitor midges throughout the UK".
Advanced Pest Solutions have tested their modified Midgeater traps in England and Wales. The English, project which was carried out at a specialist bull breeding facility, also included the use of the Barrfly air curtain, from fellow Scottish business Innovent.
Alison explained: "Innovent's air curtain is designed to prevent midges passing through it into sensitive areas. The insects simply aren't strong enough to fly through the air currents it produces.
"The air curtain, combined with the Calor supplied traps and APS's consultancy and analysis creates a comprehensive ‘assess, protect and stop', midge management system that businesses can use to reduce the exposure to the risks of midge borne diseases."
The Soil Association is calling on the Government to issue guidelines that will limit the veterinary use of the most modern penicillin-type antibiotics, to prevent the spread of a serious new superbug.Recently released minutes of a Government committee reveal that Ministers have been briefed about the emergence on a British dairy farm of a mutant strain of antibiotic-resistant E. coli which causes life-threatening cases of food poisoning, including hemorrhagic colitis and haemolytic uraemic syndrome.
The bug, known as E. coli O26 is a vera-toxin producing E. coli (VTEC), similar to the infamous E. coli O157. According to the Soil Association, what makes the discovery of this variant so significant is that this is the first time in the UK, and only the third time in the world, that VTEC E. coli has been found with an enhanced type of antibiotic resistance known as extended-spectrum beta-lactamase (ESBL), which makes it resistant to almost all antibiotics. ESBL resistance has previously been found on 57 UK farms, but until now only in strains of E. coli that cause urinary tract infections and blood poisoning.Although antibiotics are not recommended for the treatment of VTEC E. coli, scientists warn that the emergence of resistance is undesirable because these resistant bacteria are encouraged every time certain antibiotics are used, resulting in increased spread and greater risk of contaminated food products. On non-organic dairy farms, cows are routinely given antibiotics at the end of their lactation to prevent mastitis. In addition, milk from cows given antibiotics for treatment, or prevention, is often fed to calves when it contains residues and cannot be sold. However, because ESBL E. coliO26 is resistant to all the antibiotics used in ‘dry cow therapy' and many of those used for treatment, the high use of antibiotics on dairy farms will promote the rapid spread of these dangerous bacteria.Soil Association Policy Adviser, Richard Young said: "This is one of the most worrying developments in the continuing rise of ESBL E. coli. Today is the first European Antibiotics Awareness Day, but there is a distinct lack of awareness that the continuing high use of antibiotics in farming is contributing to the increase in antibiotic-resistant infections in humans."The Government often calls on doctors to prescribe antibiotics less often. But similar advice needs to be given to veterinary surgeons and farmers. Half of all antibiotics are given to animals, and there is mounting evidence that antibiotic-resistant bacteria in farm animals pass to humans. If we want antibiotics to save lives in the future as they have done in the past then the Government must provide specific recommendations based on scientific advice, and vets need to pull together with doctors to limit the use of problematic drugs."
SPVS is leading a ground-breaking new project which aims to find out how veterinary surgeons are treating a range of clinical conditions.
Two hundred practitioners are being sought to provide details of how they address clinical conditions in three study areas: small animal, equine and farm animal, on a new website: www.howdoido.org. The findings, which will be made anonymous, will eventually form the basis of a clinical benchmarking process, which will tie in with the growing trend towards evidence-based medicine.
SPVS's objective is to understand and support how clinicians work in practice and approach particular clinical cases. The Society is working alongside Dr Mark Johnson who carried out the Confidential Enquiry into Perioperative Equine Fatalities.
SPVS Junior Vice President Jacqui Molyneux said: "This is an exciting new study which will shed a lot of light on what we as clinicians are doing in practice with the eventual aim of developing a clinical benchmarking process.
"The project however will only be worthwhile if a significant number of practitioners take part, so we're encouraging vets to visit the website and find out more. It will take no longer than ten minutes to fill in each clinical case."
Intervet/Schering-Plough Animal Health has announced the launch of Nuflor Minidose - a 50% more concentrated, but less viscous solution of its proven Nuflor antibiotic.
Nuflor Minidose is licensed for the treatment and prevention of bacterial BRD. Intervet/Schering-Plough Animal Health livestock veterinary adviser Rosemary Booth MRCVS said: "It delivers all the rapid efficacy entrusted in Nuflor, but at a lower volume. Whereas a 20ml dose of Nuflor will treat a 150kg animal, the same volume of Nuflor Minidose will cover a 225kg beast. Compared with Nuflor, the new Minidose formulation is easier to administer delivering a less viscous florfenicol solution, with a 62% improvement in viscosity at 15°C and 59% at 5°C."
Rosemary added that Nuflor Minidose is effective against the main bacterial causes of pneumonia: P. multocida, M. haemolytica and H. somni. "Florfenicol is the only antibiotic offering 100% sensitivity to these three key BRD causes in recent trials and its kill effect also ensures that within 24 hours bacteria levels are low enough to prevent any re-growth."
She also pointed out that the new, more concentrated florfenicol solution presents vets with an improved batch treatment option for controlling BRD considering Nuflor is recognised as an effective metaphylactic
"Batch treatment prevents BRD from spreading. Trials with Nuflor have demonstrated the benefit of metaphylactic batch treatment of sick calves in a pen once at least 20% of the animals exhibit disease symptoms. Nuflor was significantly more efficacious than a control in preventing the spread of BRD in healthy calves exposed to infected animals," she explains.
"The bacteria responsible for BRD are found in the respiratory tract of healthy cattle and stress or a greater pathogen load - such as exposure to sick calves - can easily trigger disease. BRD bacterial numbers can double every 30 minutes and in 24 hours, one bacterium can multiply to billions. Batch treatment kills the bacteria before they multiply, release toxins and cause permanent lung damage."
New Nuflor Minidose is licensed for injection subcutaneously for the prevention of BRD at a dose rate of 4ml/45kg and has a 64-day meat withdrawal period.
The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.
ECM of France, a specialist in veterinary ultrasound solutions, has launched VIRTUAL SCAN - an ultrasound scanner for pig farmers and veterinarians. ECM says the scanner offers an alternative to screenless A-Mode Doppler devices, cheaper ultrasound devices, which are often poor quality.
VIRTUAL SCAN weighs 450 grams. It is equipped with an internal five-hour battery and a 5MHz sector probe. ECM says the instrument is extremely easy to handle - all the user needs to do is switch it on and the hand-held instrument is instantly ready to perform an ultrasound on sows.
VIRTUAL SCAN is a compact device (11cm x 18.5cm x 4.5cm) and does not require an external cable. According to the company, it can be used in any livestock facility, even inside narrow, hard-to-reach stalls. The screen is positioned in such a way that the image is always visible.
Using ECM's scanner, pregnancy tests can be performed as early as 21 days after insemination, so it is possible to re-inseminate any unfertilised sow without wasting a costly additional cycle. The image is easy to interpret. After use, the VIRTUAL SCAN ultrasound instrument is easy to clean with a damp cloth or water.
ECM, which is headquartered in Angoulême (in south-western France), develops and manufactures specialist veterinary-science devices. The company also provides training in ultrasound techniques, the correct way to move the probe and how to interpret the ultrasound image.
For more information, please contact:
Simon QuarmbyHOLMEFIELD Farm ServiceAgriculture HouseMurton LaneMurtonYorkT019 5UF
tel : (44) 1904 481.490fax : (44) 1904 481.211email : simon@hfsvets.com
Or visit: http://www.agroscan.com/ and http://www.ecmscan.com/
The Animal Medicines Training Regulatory Authority (AMTRA) is launching its new Continuous Professional Development (CPD) scheme today, designed to ensure that the Authority's registered Suitably Qualified Persons (SQPs) keep up to date with the latest animal medicines information.
In order to maintain their SQP status, every SQP will have to achieve a minimum number of CPD points during each AMTRA CPD period, running for two years from July to June. However, in the initial stages of the scheme, this first period will run for 33 months, from October 2008 to June 2011, allowing AMTRA to fine tune the system if required and give its SQPs time to get used to the new structure.
During these CPD periods, SQPs are required to obtain a minimum number of CPD points depending on their SQP type:
SQP Type: Modules; VPS medicines supplied; CPD PointsR-SQP: FAM+EQM+CAM; All VPS Medicines; 70 pointsG-SQP: FAM+EQM; VPS-farm animals and equines only; 50 pointsK-SQP: FAM+CAM; VPS-farm and companion animals only; 50 pointsE-SQP: EQM+CAM; VPS-equines and companion animals only; 50 pointsL-SQP: FAM; VPS-farm animals only; 30 pointsJ-SQP: EQM; VPS-equines only; 30 pointsC-SQP: CAM; VPS-companion animals only; 30 points
(FAM - Farm Animal Module, EQM - Equine Module, CAM - Companion Animal Module)
In essence, this means that 20 points are required per animal group, plus a further 10 points. Dr Roger Dawson, Secretary of AMTRA comments, "There is no maximum number of CPD points that SQPs can accumulate and we will be encouraging them to gain the benefit of as much CPD as they can."
Those SQPs who do not achieve the minimum number of CPD points by the end of the period will not be eligible to renew their status for the following year. However, such SQPs will have the option of sitting an examination before the end of that CPD period in order to maintain their SQP status and eligible be to renew for the next year.
SQPs will have a range of avenues through which to gain CPD points, ranging from four types of AMTRA-accredited CPD Events, to online study and personal study. With CPD Events and online studies, accreditation and points will be awarded by the AMTRA CPD Accreditation Panel. With personal study, AMTRA accepts a degree of self-certification of this form of CPD, however the points gained in this way are limited to a relatively small proportion of the minimum required in a CPD period.
Throughout a CPD period, all SQPs are required to attend at least ONE CPD Event. These events will comprise a range of modules that will be assessed for coverage, of relevant topics ranging from legislation, regulations and prevalence & effects of parasites and pathogens, to control of disease management, resistance, warnings and SARS.
Dr Dawson says, "The new CPD scheme has the necessary flexibility to allow SQPs to gain the required CPD points via a number of routes, from accredited CPD events and online study to personal study. Furthermore, the structure of the scheme ensures that their studies will be properly assessed to ensure they have gained the necessary knowledge to secure their CPD points."
Fort Dodge, which supplies Bluetongue vaccine in continental Europe, has licensed its cattle vaccine in the UK and is now launching the product onto the UK market.
The company has already won and met tenders from several European governments, including France, Spain, Italy, Portugal Germany, Switzerland, Belgium and the Czech Republic for its Zulvac 8® Bovis vaccine and says it is the only international company to have produced vaccines for the most commonly occurring serotypes of the disease including 8, 4 and 1.
Approved by the VMD with a Provisional Marketing Authorisation, Zulvac 8 is available in 50 dose and 10 dose packs. The key claims are active immunisation against Bluetongue serotype 8 of cattle from 2.5 months old and a significant reduction of viraemia.
The vaccine is administered in 2 x 2 ml doses at three week intervals given by intra muscular injection and the product is supported by a fixed 2ml multidose applicator with Sterimatic needle protector and cleaning system to ensure accurate dosing and hygienic conditions.
John Hanley, Managing Director of Fort Dodge UK, said: "We were first to market with our Zulvac 8 product in three European countries and have received an Award for Agricultural Merit from the Spanish Government for our work in Bluetongue control. Following the licensing of Zulvac 8 Bovis in the UK we now have the opportunity to launch the product onto the UK market.
"In terms of pricing, Zulvac 8 is competitive per dose against other products in the market and it is supported by the experience gained in Europe with millions of animals already vaccinated. We're delighted that the VMD have authorised the vaccine and believe its availability can play a key role in protecting the UK's cattle from this dreadful disease."
The product is authorised for use by cattle farmers in the protection zone only, and will require veterinary prescription. Farmers can administer the vaccine to their cattle and the 2ml intra-muscular injection will be an advantage in aiding administration especially when used with Zulvac Bovis applicator with sterimatic needle protector and cleaning system.
The first batches will be available from veterinary wholesalers from week commencing 22nd September 2008.
The University of Nottingham, with funding worth £2.2m, is to carry out a study of the most common cause of Bovine Mastitis in the UK - Streptococcus uberis (S. uberis). If researchers can identify which parts of the bacteria enable the infection their results could lead to the production of an effective vaccine.
James Leigh, Professor of Molecular Bacteriology, who has recently joined the School of Veterinary Medicine and Science, said: "We hope to uncover bacterial antigens of potential use in vaccines aimed at preventing bovine mastitis and provide a detailed understanding of how animals can fight off the disease."
S. uberis is responsible for a significant proportion of clinical mastitis worldwide - but unlike many other bacteria that cause the disease, S. uberis is also in the environment - it is found in pasture and bedding and can even colonise the cow at other body sites with no ill effect - so it is difficult to see how it can be controlled by changes to animal husbandry and milking-time hygiene.
With funding from the Biotechnology and Biological Sciences Research Council (BBSRC) the School of Veterinary Medicine and Science has established research laboratories at the Institute for Animal Health (IAH). The project is being conducted in collaboration with Dr Tracey Coffey's Bovine Genomics group based at IAH and other groups at the Royal Veterinary College, the US Department of Agriculture in the UK and the University of Oxford.
Professor Leigh said: "We will use state-of-the-art molecular technology to determine the differences between strains of S. uberis that can and cannot cause disease. Proteins that are only present in the disease causing strains hold the key to determining which components are essential for infection. We will show which of these proteins are most likely to make an effective vaccine by producing strains of S. uberis which lack the ability to produce each of these proteins; if a strain lacking a particular protein is less able to cause disease then this protein is important for the disease process and becomes a candidate for vaccine development."
The team also want to identify any parts of the immune response in the dairy cow which can be altered to prevent the disease - this information could subsequently be used to develop drugs that interfere with the chemical messages that lead to inflammation and therefore reduce the level of disease.
Defra has announced the detection of Bluetongue in 18 imported cattle on premises near Bishop Auckland, County Durham. The animals originated from within the BTV8 Restricted Zone in Germany and were detected as a result of post-import testing carried out by Defra on all Bluetongue susceptible animals arriving from Continental Europe.
This is the fourth incidence of infected animals being imported to the UK. Alongside the premises in East Sussex, Hertfordshire and Devon identified in August, the imported animals will remain under restrictions.
As of 1 September the whole of England and Wales is now in a Protection Zone and approximately 30 million doses of vaccine have so far been made available to farmers throughout England and Wales to protect their stock. However, it may take up to six to eight weeks from now for livestock keepers in the North of England and Wales to have had sufficient opportunity to vaccinate their livestock and to gain immunity (at least three weeks in sheep, and six weeks in cattle).
To allow livestock keepers in those areas sufficient opportunity to protect their animals, and while further veterinary investigations are carried out, these particular infected animals will remain under restriction until late October. Any further positive import cases detected may also be restricted for a period of time depending on veterinary risk assessment, while vaccination continues.
Deputy Chief Veterinary Officer, Alick Simmons said: "This incident shows how important it is for farmers to consider potential disease risks when buying stock, regardless of source. Buyers need to consider how best to protect their own businesses and those of their neighbours and make sure they are clear about the stock they are intending to buy.
"I also want to remind farmers about the importance of vaccination. It is the only effective tool to protect susceptible animals from Bluetongue. Recent evidence indicates a drop or delay in vaccine take-up in counties recently brought into the Protection Zone. Sales data for some of those counties suggest that the number of animals vaccinated in these areas could be as low as one in three, and in Northumberland and Cumbria, the most recent counties brought into the Protection Zone, as low as one in five.
"The threat from Bluetongue is present and real, as shown by the most recent import cases. Vaccination as a preventive measure is therefore more important than ever, so the message to the industry remains clear: don't hesitate, vaccinate".
CEVA Animal Health is giving away a key ring torch with every three bottles of Rehydion gel®, its product for scouring calves.CEVA says the deal is to highlight the fact that Rehydion gel® is currently the only oral rehydration treatment that can be added to milk, with guaranteed milk clotting. According to the company, Rehydion gel® has faster, guaranteed milk clotting and helps to maintain a low abomasal pH. Its high palatability and efficient dilution in milk allows weight gain to continue, even in cases of severe scour. It also has a high Strong Ion Difference (SID) which effectively suppresses acidosis. Rehydion gel® is fast to mix by simply shaking the hand-held bottle. Rehydion gel's® consistency means that precise doses of alkalinising agents and electrolytes can be squeeze-delivered with ease. In beef systems the product is time-saving, convenient and minimises stress as it can be given neat, meaning there is need for the calf to be separated from its dam. One bottle provides enough for eight, two-litre calf feeds or 160 feeds for lambs. The distinctive yellow top also acts as a handy measuring cap.
Further information and product literature is available from Martin Gough on 01494 781510.
Dickson Company has launched the Dickson Alarm Thermometer, a tool to ensure that vaccine and drug storage temperatures in both refrigerators and freezers fully comply with regulatory requirements.
Featuring tamper-resistant audible and visual alarms, the Dickson Alarm Thermometer costs US$59 for a two probe model (MM125) that can monitor both refrigerators and freezers simultaneously and US$49 for a single probe model (MM120).
Both the MM125 and MM120 models are continuous, calibrated and certified thermometers that are able to monitor temperatures in the -58 to +158°F (-50 to +70°C. For more technical details on Dickson Alarm Thermometers see (www.dicksondata.com/product/model_MM120.php).
Product inquiries can be directed to Dickson customer service at dicksoncsr@dicksondata.com, or calling 800-757-3747 or +1-630-543-3747 outside the US, FAX +630-543-0498 or by writing Dickson, 930 South Westwood Avenue, Addison, IL 60101, USA.
The British Occupational Hygiene Society (BOHS) has announced the publication of a book on controlling skin exposure and wet work. The book aims to fill a knowledge gap about dermal exposure risk management in workplaces which are particularly affected, such as veterinary practices.
The consequences of a failure to adequately control dermal exposure to hazardous agents do not always become apparent until years after exposure, and because of this, many employers are either ignorant of the consequences or ignore the potential for ill-health until it is too late. In Great Britain, over 29,000 people are suffering from work-related skin disease and every year over 3,500 new cases are reported. Alongside this, many workers are unaware of the ways in which skin comes into contact with chemicals, or how dermal exposure can contribute to inadvertent inhalation and ingestion exposure.
Healthcare workers are susceptible. Vets and nurses are, for example, at risk from disinfectants, detergents, wet-work, latex gloves, anaesthetics, antibiotics and antiseptics, phenothiazines, formaldehyde, glutaraldehyde and liquid chloroxylenol.
The book provides an introduction to the structure and functions of the skin, information about the diseases caused by dermal exposure and the occupations and chemicals involved, regulatory requirements related to dermal exposure at work, exposure and risk assessment, and risk management strategies. It is both comprehensive and accessible, and clearly illustrated with photographs, figures and tables throughout, ensuring that it will be of practical use. As a result, BOHS believes that it will make an important contribution to increasing knowledge about control of dermal exposure, and encourage more effective control measures to be introduced in workplaces.
‘Controlling Skin Exposure to Chemicals and Wet-Work' is available for £19.99 and can be purchased on-line via RMS Publishing, www.rmspublishing.co.uk/BOHS.html and Amazon, or by posting/faxing the order form which can be downloaded from the Publications section of the BOHS website.
With just a few days to go before the first anniversary of bluetongue being detected in England, the JAB campaign group is urging farmers to vaccinate their livestock to stop the disease from taking hold in this country as it has in Europe.
So far this year France has reported 4,543 cases of bluetongue, including cases in Calais, and the Netherlands has just confirmed its first case of the disease in 2008. The affected small holding reported a sick cow found with serotype eight which had not been vaccinated against infection.
With the threat of bluetongue re-emergence in the UK growing by the day, JAB leaders have issued a reminder to farmers to contact their vets as soon as their region is in the protection zone and vaccine is available.
In a statement JAB said: "The amount of cases being reported across Europe shows the disease is on the move. This most recent case in Holland demonstrates that not vaccinating livestock leaves farmers vulnerable to outbreaks now the midge season has started.
"The industry has rallied behind the JAB campaign and has done tremendously well in terms of vaccination. Nearly 19 million doses have already been made available to English farmers, and with another nine million doses planned to be released in the coming weeks we need those areas that are new to the protection zone to vaccinate as soon as they are able. We must remember bluetongue could already be circulating in areas where outbreaks occurred last year so the risks to everyone are very real.
"The explosion in the number of cases on the continent also acts as a timely reminder to those farmers in the current protection zone who have not vaccinated and the dangers this presents to their unprotected livestock
"We are entering the peak period for midge activity so vaccination is the only way to prepare and protect us from any potential outbreaks that may emerge in the coming weeks."
Merial Animal Health has announced the first delivery of its bluetongue vaccine, BTVPURTM AlSap, in the UK. The shipment of just over 2 million doses is the first of several batches scheduled over the summer months and forms part of Merial's commitment to Defra to supply 13 million doses for England and Wales. Despite bluetongue disease not yet re-emerging in the UK this year, Merial strongly encourages farmers to protect their livestock from this potentially debilitating disease. Head of Production Animal Business, Graham Davenport said: "Our experience in continental Europe over the past four years has shown just how imperative vaccination is for vets and farmers in controlling this disease in the field. Recent outbreaks in France are a reminder that there is no room for complacency. Over the past few weeks we have been working closely with the members of JAB (Joint Action against Bluetongue) and strongly advocate that farmers should act on their advice: Don't hesitate, vaccinate."Information for veterinary professionals and livestock owners on BTVPUR AlSap can be found at www.merial.co.uk. Veterinary surgeons can also obtain information by calling 0800 592699 or emailing ukbluetongue@merial.com.
Vets, consultants and other advisors should encourage dairy farmers to make use of available information to help improve their herd's performance and profitability through breeding. This is the message from DairyCo breeding+ director, Marco Winters, who says farmers should use genetics to improve not only milk production, but also health, welfare, management and type traits.
Breeding briefs, a new booklet from DairyCo, identifies some genetic improvement tools that allow farmers to make better breeding decisions and concentrates on how to use them in practice. And for those who feel confronted by an overload of information, the booklet helps identify the figures to seek out and prioritise.
Breeding decisions are cumulative: their effects build up over the generations so a problem can be introduced or cured over just a few years. A series of poor breeding decisions can mean the difference between profit and loss; even between a business's survival and failure. Yet the time, cost and effort needed for a good breeding decision to be made is much the same as those needed for a bad one.
Mr Winters says: "High quality cattle are at the heart of profitable dairy farming and this requires good quality genetics. Without these, however good farmers' management, there is a ceiling to their herd's performance and profitability. Vets, consultants and other dairy advisers have an important role to play in helping farmers access the information they need to make informed decisions."
DairyCo Breeding briefs is available to download from http://www.dairyco.org.uk/. To request a pdf version by email call 01285 646510 or email: publications@dairyco.org.uk.
The Royal College of Veterinary Surgeons has set up a new Veterinary Legislation Group to consider proposals for changes in veterinary regulation, in the light of the Environment, Food and Rural Affairs Committee's inquiry into the current Veterinary Surgeons Act, and the Government's response to the EFRA Committee's report.
The new group, which will be chaired by RCVS Council Member and Dean of Glasgow Veterinary School, Professor Stuart Reid, will be tasked with taking a fresh look at changes that need to be made to the current legislative framework, and how these might be accomplished. It will not restrict itself to looking at a replacement for the Veterinary Surgeons Act, but will consider other ways that changes can be made in the short- and long-term.
The Group will meet in September, and comprise RCVS Council members and non-members - both lay people and veterinary surgeons. Once the RCVS position has been clarified, further discussion will follow with DEFRA, the BVA and the profession.
Responding to the Government's response to the EFRA Committee report, RCVS President Jill Nute said: "We welcome the fact that DEFRA is willing to consider any detailed proposals that might come forward from the profession, although we accept that DEFRA itself does not have time or resources to be proactive at this stage.
"We are also pleased that Government acknowledges that the veterinary nursing profession has come of age and that the time is right for the regulation of veterinary nurses to be taken forward, although again it is disappointing that DEFRA does not have the resources to progress this at present.
"Finally, we welcome the suggestion that the Presidents of the BVA and the RCVS meet with the Chief Veterinary Officer to discuss plans and to what extent DEFRA can help us - accepting the fact that DEFRA, like the RCVS, feels that a piecemeal approach may not be the most effective," she concluded.
Lord Rooker, Minister for Sustainable Food, Farming and Animal Health has announced seven new members to the Veterinary Residues Committee (VRC).
The VRC’s role is to advise the Chief Executives of the Veterinary Medicines Directorate (VMD) and the Food Standards Agency (FSA) on the formulation of the residues surveillance programmes and on the significance of the results in terms of consumer safety.
The seven new members who have been appointed to serve on the VRC from January 2009 until December 2012 are:
The appointments were undertaken in accordance with the Code of Practice issued by the Office of the Commissioner for Public Appointments.
THE Society of Practising Veterinary Surgeons (SPVS) has published its annual Salary Survey, which provides a guide to what full time assistants are now earning.
The survey, which asked the society's members and anyone on the RCVS Register qualified for under three years to provide details about employees' salary levels, uniquely provides a breakdown of what full-time assistants are earning.
Respondents were asked to provide details of their basic salaries together with any benefits in kind such as rental accommodation, access to a car and CPD allowances, and total remuneration packages were calculated.
The survey, which is distributed along with the annual Fees Survey to SPVS members as a key benefit of membership, provides a breakdown of minimum, average and maximum salaries over categories ranging from location to the number of years qualified.
For the second year, student loan levels are featured, which, worryingly, highlights the increasing number of students graduating with large value loans.
Richard Hillman, SPVS President, said: "I very much welcome the publication of this important annual survey, which comes at a time when vet salaries and the fees we charge are under fire. It is interesting to note that the recent ‘league table' which effectively labeled us the ‘fat cats' among small businesses was based on the minority of corporate practices."
He added: "Our survey provides a very valuable base for employers to develop a transparent pay scheme and for employees to negotiate. It is particularly useful with new legislation on greater transparency of pay scales in businesses and the outlawing of salary ‘secrecy clauses' together with the Government's push for equality in male/female pay awards."
The SPVS annual Fees Survey, which provides a breakdown of fees charged across the small animal, cattle and equine sectors, will be published in September.
SPVS is run by practitioners for practitioners and if you'd like further information on the courses and membership benefits that SPVS offers, please contact the secretariat on 01926 410454 or visit the web site at www.spvs.org.uk
This is the call to Government from an industry-wide stakeholder group that has joined forces and vowed to do everything in its power to stamp out the disease which is seeing upwards of 28,000 cattle a year culled.
The industry stakeholder group has put its name to an eight-point statement of agreement following the non-decision announced by the Secretary of State, Hilary Benn, on dealing with bTB.
Included in the eight points is a call for an independent body to take on the future decision making for animal health; a commitment of non-participation in the TB Partnership Group as announced by the Secretary of State; and an industry policy of non-participation in discussions on cost sharing and responsibility on animal health and welfare issues.
The NFU, which hosted the stakeholder meeting, has been heartened by a report, also out today, from the Efra select committee on badgers and cattle TB which says the Government is playing down the serious nature of bovine TB. In its response the committee, chaired by the Rt Hon Michael Jack MP, says:
NFU Deputy President Meurig Raymond said: “The industry feels let down and angered by the Government’s abdication of responsibility around this devastating disease. We have been left with no choice but to walk away from any attempt by Government to validate their ‘policy’ decision and pass responsibility for controlling this disease to the already beleaguered cattle sector. The Efra committee’s report reinforces both the fact that the Government has made the wrong decision and the need for something to be done now rather than waiting for vaccines to become available years down the line which will be too late for many farmers whose businesses are being decimated by this disease. The Efra report recognises the value of the VLA9 culling proposal put together by the NFU and other industry bodies for the South West of England. Hilary Benn has been invited to meet the people involved with VLA9 but has declined to do so which, given the hard work that has been put in on the plan, is very disappointing.”